Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Nicholas Galakatos
Person

Nicholas Galakatos

Tracked across 1 events · 7 articles · First seen Feb 23, 2026 · Last active Feb 23, 2026

Sentiment
0
Attention
4
Events
1
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 0
Business
Blackstone Life Sciences, Johnson & Johnson Fund Bleximenib
Nicholas Galakatos, Global Head of Blackstone Life Sciences, expressed excitement about the agreement with Johnson & Johnson, emphasizing the potential of bleximenib's clinical data and Johnson & Johnson's expertise.
Feb 23, 2026 · 7 articles
Relationships (1)
Blackstone Life Sciences Global Head ↔ Nicholas Galakatos Nicholas Galakatos is the Global Head of Blackstone Life Sciences.
NEWSDESK
Track Nicholas Galakatos live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.